Drawing for APTALIS

USPTO serial 85325612

APTALIS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
LOTT, MAUREEN DALL
Law office
PETITIONS OFFICE

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with APTALIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemicals for the pharmaceutical sector, namely, chemical formulations that affect release properties for use in the manufacture of pharmaceuticalsACTIVE
005A full line of pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals; dietetic foods and substances, namely, nutritional supplements, nutritionally fortified beverages, nutritional drinks and drink mixes for use as a meal replacement, all adapted for medical and clinical use; a full line of medicinal preparations, both prescription and over-the-counter, for use in connection with humans and animals; pharmaceutical preparations in the form of a liquid, powder, tablet, capsule, granule and gel, for the treatment of gallstones and disorders of the liver, intestines, stomach, pancreas, lungs, esophagus, and gallbladder; pharmaceutical products, namely, antibiotics, anti-inflammatory preparations, antifungal preparations, antispasmodic preparations, anti-ulcerous preparations, tranquilizers, anti-histaminic preparations, and pancreatic enzymes for gastro-intestinal symptoms and diseases; pharmaceutical products for regulating weight; vitamins; spasmolytic preparations, namely, pharmaceutical preparations for use in relieving spasms; preparations in the form of liquid or powders intended for dialysis, namely, liquid-based and powder-based pharmaceutical preparations for use in treating the kidney during dialysis; pharmaceutical preparations for the diagnosis and treatment of tumors; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous systemACTIVE
010Medical devices, namely, lasers, mucus clearance devices, hypodermis and acupuncture needles, syringes, medical apparatus for facilitating the inhalation of pharmaceutical preparationsACTIVE
016Printed matters in the field of medicine, namely, books, brochures, pamphlets and tabloidsACTIVE
035Providing an internet website featuring business information in the fields of medicine and pharmaceuticals; providing an intranet website featuring business information in the fields of medicine and pharmaceuticalsACTIVE
041Organization of educational services, conferences, symposiums and educational teaching programs, namely, organization of educational presentations, classes and workshops in the field of medicine and physical disorders, intended to encourage the exchange of information concerning the treatment of various physical disorders, and distributing course materials provided in connection therewithACTIVE
042Research and development of technology in the field of pharmaceuticals for use in the pharmaceutical industryACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 7, 2015PCDEPETITION TO DIRECTOR DENIED
Jul 6, 2015APETASSIGNED TO PETITION STAFF
Jun 2, 2015TPDRTEAS PETITION TO DIRECTOR RECEIVED
May 29, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 29, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 29, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 5, 2014MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 5, 2014ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Nov 5, 2014GAUNNOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Nov 5, 2014GAUDNOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Nov 5, 2014NAUDREPORT UNRESPONSIVE AMENDMENT - COMPLETED
Sep 16, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 9, 2014GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Apr 9, 2014GNSIINQUIRY TO SUSPENSION E-MAILED
Apr 9, 2014CNSISUSPENSION INQUIRY WRITTEN
Feb 12, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 6, 2013ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Oct 5, 2013GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 5, 2013GNSLLETTER OF SUSPENSION E-MAILED
Oct 5, 2013CNSLSUSPENSION LETTER WRITTEN
Sep 17, 2013TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2013CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2013ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 1, 2013GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 1, 2013GNSIINQUIRY TO SUSPENSION E-MAILED
May 1, 2013CNSISUSPENSION INQUIRY WRITTEN
May 1, 2013ALIEASSIGNED TO LIE
Nov 1, 2012GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 1, 2012GNSLLETTER OF SUSPENSION E-MAILED
Nov 1, 2012CNSLSUSPENSION LETTER WRITTEN
Oct 11, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 10, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 10, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2012ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 10, 2012GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2012GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 10, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 9, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 8, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 8, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2011DOCKASSIGNED TO EXAMINER
May 24, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2011NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance